Through correlation analysis, we suggest that the adjustment of sirolimus (SRL) blood concentration should be made in consideration of the child's physiological and biochemical parameters.

Pharmacogenomic factors and interactions with concomitant medications have a substantial impact on sirolimus blood concentration profiles, underscoring the necessity for well-designed prospective cohort studies in this field.